LIFT

Athira Pharma Announces Completion of Enrollment in Phase 2 ACT-AD Trial Evaluating ATH-1017 for Mild-to-Moderate Alzheimer’s Disease

Retrieved on: 
Friday, October 22, 2021
ACT, Safety, Method, Dementia, ERP, MET, LIFT, GLP, Athira Pharma, Rapunzel's Tangled Adventure (season 2), HGF, Caregiver, Memory, Patient, NASDAQ, Doctor of Philosophy, Toxicology, Hepatocyte growth factor, Cognition, Clinical trial, Neurodegeneration, L. Athira Krishna, AD, IND, EEG, Quantitative electroencephalography, GLOBE, Central nervous system, Plasma, Pharmaceutical industry, Medical imaging

BOTHELL, Wash., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced today that it has completed enrollment in ACT-AD, a Phase 2 randomized, placebo-controlled study of ATH-1017 in patients with mild-to-moderate Alzheimer’s disease. ATH-1017 is a small molecule designed to enhance the activity of Hepatocyte Growth Factor (HGF) at its receptor, MET, which are expressed in the central nervous system to promote brain health and function. Athira expects to report topline results from the trial in the first half of 2022.

Key Points: 
  • We look forward to building on this momentum and sharing topline results from this Phase 2 trial in the first half of 2022.
  • The completion of enrollment in ACT-AD is an important clinical milestone for Athira.
  • By focusing on neuronal network recovery, ATH-1017s novel mechanism of action is agnostic to the underlying disease pathology of Alzheimers and other dementias.
  • Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimers and Parkinsons disease dementia.

Martin Robert, PhD. Joins Pleio, Inc. to Energize Innovation in Patient Engagement

Retrieved on: 
Thursday, October 21, 2021
Science and Technology Education Innovation Center, Psychology, Science and technology in Asia, LIFT, LinkedIn, Creativity, Knowledge, Twitter, Instructional simulation, Cognitive science, Patient, Marketing, View, Gaps, Enrique Dussel, Inc., Leadership, HIPAA, TCPA, AI, Multimedia, Artificial intelligence, Education, Universitate metro station, Doctor of Philosophy, Pharmacy, Technology education, Physician, Medical device, Medicine, Management

NEW YORK, Oct. 21, 2021 /PRNewswire/ --Pleio, Inc announced today that Martin Robert will head up their new Product innovation lab.

Key Points: 
  • NEW YORK, Oct. 21, 2021 /PRNewswire/ --Pleio, Inc announced today that Martin Robert will head up their new Product innovation lab.
  • Pleio, Inc. meets patient demands and hires a new PhD to leverage AI innovation and product development.
  • Over the last 25 years, Martin has worked in specialized medical education and communications companies to blaze trails in innovation and new product development.
  • Pleio is a leading patient support company focused on "patients as people" to help close the adherence gaps and drive better patient engagement.

LifeSpeak Acquires ALAViDA to Deliver Virtual, Evidence-Based Substance Use Support to Millions of People Around the World

Retrieved on: 
Thursday, October 14, 2021
Professional Services, Mental Health, Health, Technology, Insurance, Human Resources, Software, Risk, Prevalence, Organization, Technology, Industry, Smartphone, Fortune 500, Awareness, Earnout, Growth, Workplace, Physician, CBT, Privacy, Business, Masterpiece Inc. v. Alavida Lifestyles Inc., TSX, Government, Patient, Science, Substance use disorder, Phrase, LIFT, Mental health, Substance abuse, Company, SUD, CEO, Software as a service, Acquisition, Pharmaceutical industry, Risk management, Health insurance, ALAViDA Health Ltd., LifeSpeak Inc., ALAVIDA HEALTH LTD., LIFESPEAK INC.

The ALAViDA technology platform delivers on-demand substance use support through the privacy of an individuals smartphone and self-guided resources available anytime, anywhere.

Key Points: 
  • The ALAViDA technology platform delivers on-demand substance use support through the privacy of an individuals smartphone and self-guided resources available anytime, anywhere.
  • We are excited to join forces with LifeSpeak in removing barriers to care, said Elliot Stone, co-founder and CEO of ALAViDA.
  • "ALAViDA has reshaped the substance use management industry by providing gold-standard, evidence-based collaborative care that is powered by technology.
  • Combining efforts with LifeSpeak gives us the global reach to make a positive impact on millions of people around the world.

LifeSpeak Inc. Acquires LIFT Digital Inc., to Capitalize on Burgeoning Global Demand for Corporate Wellness Solutions

Retrieved on: 
Tuesday, October 12, 2021
Professional Services, Mental Health, Health, Technology, Fitness & Nutrition, Human Resources, Software, Company, Â, Mindfulness, Mental health, Risk, Software as a service, Yoga, Phrase, Government, Canadian Mental Health Association, Growth, Instagram, Health, TSX, LIFT, CEO, Solution, Partnership, Acquisition, Insurance, Fortune 500, Organization, Risk management

Adding LIFT to the LifeSpeak family of companies allows us to meet the growing demand for physical wellbeing solutions from companies that understand the link between physical and mental health.

Key Points: 
  • Adding LIFT to the LifeSpeak family of companies allows us to meet the growing demand for physical wellbeing solutions from companies that understand the link between physical and mental health.
  • The LIFT platform guides users through wellness journeys with personalized recommendations, access to experts, community-based challenges, and social engagement with like-minded members.
  • LIFT session is a digital fitness platform that helps wellness providers offer premium virtual fitness services to their clients.
  • By offering services through wellness providers and businesses, LIFT session offers its online fitness platform to millions of customers globally.

Kearney Launches Digital Model Factory

Retrieved on: 
Wednesday, October 6, 2021
Adoption, Partnership, AGV, Solution, Forbes, Automotive industry, U.S. Department of Defense Strategy for Operating in Cyberspace, Workforce, Original equipment manufacturer, LIFT, Sport, Flow management, Structural load, CEO, Industry, World Economic Forum, Automated guided vehicle, Fourth Industrial Revolution, NVIDIA, Technology, Drishti, Safety, Machine learning, Ecosystem, Movement, DMF, Defense Industry Sector (Ethiopia), Office, Department, Satellite navigation device, Warehouse, Medical device

CHICAGO, Oct. 6, 2021 /PRNewswire/ --Global consulting firm Kearney and strategic partner LIFT Manufacturing Institute today officially launched the Digital Model Factory, a hands-on facility where industrial companies can explore how to best apply Industry 4.0 technologies in their operations.

Key Points: 
  • CHICAGO, Oct. 6, 2021 /PRNewswire/ --Global consulting firm Kearney and strategic partner LIFT Manufacturing Institute today officially launched the Digital Model Factory, a hands-on facility where industrial companies can explore how to best apply Industry 4.0 technologies in their operations.
  • The new Digital Model Factory ( DMF ) is located in LIFT's 100,000 square foot facility in Corktown, Michigan a technology hub for the automotive, aerospace, and industrial sectors.
  • "Together, Kearney and LIFT will help companies across the United States take the critical next step toward making digital manufacturing a reality on their factory floors," said Doug Mehl , Kearney Partner and the firm's Global Lead for Industry 4.0 Strategy.
  • "Kearney's DMF moves beyond envisioning Industry 4.0 to experiencing what it actually means to implement this remarkable range of emerging technologies," noted Azaz Faruki, a Kearney Principal who directs daily operations at the new Digital Model Factory.

Wells Fargo NeighborhoodLIFT Program Returns to Houston to Create 300 Homeowners

Retrieved on: 
Tuesday, October 5, 2021
Professional Services, Philanthropy, Other Professional Services, Other Philanthropy, Finance, Banking, Wells Fargo, Language, Tax, HUD, Black, Investment management, Central Time, Federal, News, Multimedia, LIFT, Â, WFC, Investment banking, Topical steroid withdrawal, Federal Financial Institutions Examination Council, Program, Housing, Corporation, COVID-19, Commercial bank, Learning, Anxiety, District, NYSE, Wealth, Education, Health insurance, Insurance, Tutoring, Real estate

We appreciate the efforts of Wells Fargo, NeighborWorks America and its local affiliates to bring the NeighborhoodLIFT program to Houston again and help put homeownership within reach for hundreds of households.

Key Points: 
  • We appreciate the efforts of Wells Fargo, NeighborWorks America and its local affiliates to bring the NeighborhoodLIFT program to Houston again and help put homeownership within reach for hundreds of households.
  • Todays expansion of the NeighborhoodLIFT program celebrates more than 25,100 homeowners created through 82LIFT launches nationwide since 2012.
  • Nurse Amanda Bridgewater purchased a home through Houston NeighborhoodLIFT in 2019 and learned valuable lessons about homeownership through the program.
  • News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.

Bayer Appoints New General Managers for Nutritionals and Digestive Health Businesses

Retrieved on: 
Tuesday, October 5, 2021
Retail, Health, Other Retail, Other Health, Fitness & Nutrition, Pharmaceutical, Biotechnology, Intracellular digestion, Vicks, Align, Molecular biology, Bayer, Trust, OTC, Ball, Ageing, Multimedia, General manager, LIFT, Management, Digestive, Senior, Sheffield, P&G, Group, University, Acquisition, CPG, No, Psyllium, Growth, LG Household & Health Care, Science, MBA, Doctor of Philosophy, Kutztown University of Pennsylvania, Merck Consumer Health, Statistical Applications in Genetics and Molecular Biology, Pharmaceutical industry

Bayer Consumer Health has appointed new General Managers to lead its Nutritionals and Digestive Health businesses, two of its fastest growing categories.

Key Points: 
  • Bayer Consumer Health has appointed new General Managers to lead its Nutritionals and Digestive Health businesses, two of its fastest growing categories.
  • View the full release here: https://www.businesswire.com/news/home/20211005005771/en/
    Lisa Perez, General Manager and Vice President Marketing - Nutritionals of Bayer Consumer Health (Photo: Business Wire)
    After 16 years at Bayer, Lisa Perez is being named General Manager and Vice President Marketing Nutritionals.
  • In addition, David Ball has been appointed General Manager and Vice President Marketing Digestive Health.
  • I look forward to partnering with them both to drive further growth for our Nutritionals and Digestive Health categories.

VELARY to Launch 4-Hour Flight UAV Wildfire Solutions at Commercial UAV Expo Americas

Retrieved on: 
Tuesday, September 7, 2021

WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- VELARY , an American aviation technology company, will unveil its 4-hour + flight Unmanned Aerial Vehicle (UAV) technology during the Commercial UAV Expo Americas from September 7-9 at the Mirage in Las Vegas.

Key Points: 
  • WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- VELARY , an American aviation technology company, will unveil its 4-hour + flight Unmanned Aerial Vehicle (UAV) technology during the Commercial UAV Expo Americas from September 7-9 at the Mirage in Las Vegas.
  • He added, "Sustainable, effective, and cost efficient solutions are critically needed in the immediate and near term, which is why VELARY has decided the time is now to present our next-generation aviation solutions to the world during the 2021 Commercial UAV Expo Americas."
  • By safely integrating into existing airspace, VELARY's scalable, versatile, environmentally conscious UAV solutions will complement and, in some cases, replace costlier helicopters and airplanes.
  • By bringing together vertical mobility solutions with AI, data, and cloud services, VELARY is meeting the future with innovative technologies and human ingenuity.

Wells Fargo NeighborhoodLIFT Program Creates Pathways to Homeownership

Retrieved on: 
Monday, August 30, 2021
Other Consumer, Construction & Property, Finance, Banking, Professional Services, Philanthropy, Consumer, Other Philanthropy, Residential Building & Real Estate, People, Wealth, Commercial bank, Investment management, Black, Program, Topical steroid withdrawal, Investment banking, District, Roy, Washington, The Pew Charitable Trusts, Wells Fargo, HACE, Pew, Corporation, LIFT, Tax, WFC, NYSE, Multimedia, NHS, Federal Financial Institutions Examination Council, HUD, Federal, Education, Housing, Â, News, COVID-19, Income, Real estate, Insurance

Todays expansion of the NeighborhoodLIFT program follows similar initiatives in 2012 and 2016 that created more than 1,000 homeowners in Philadelphia with a combined $16 million provided by Wells Fargo.

Key Points: 
  • Todays expansion of the NeighborhoodLIFT program follows similar initiatives in 2012 and 2016 that created more than 1,000 homeowners in Philadelphia with a combined $16 million provided by Wells Fargo.
  • (Photo: Wells Fargo)
    To address this ongoing issue, vice chairman of Wells Fargo Public Affairs Bill Daley announced the NeighborhoodLIFT program today in front of the West Philadelphia home of Roy Washington, who received down payment assistance at a previous LIFT initiative in Philadelphia.
  • Todays expansion of the NeighborhoodLIFT program is Wells Fargos 81st LIFT launch and follows similar Philadelphia initiatives in 2012 and 2016 that created more than 1,000 homeowners with a combined $16 million provided by Wells Fargo.
  • News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.

New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms

Retrieved on: 
Monday, August 30, 2021
Red encrusting sponge, European Association of Urology, Standard of care, Anesthesia, University, Edema, Urology, American Urological Association, Prostatic urethral lift, Stent, GLOBE, Graduate school, Prostate, Research, Tissue, Hematuria, LUTS, Man, Health, LIFT, Emergency medicine, Heat, PUL, Prostate cancer, NYSE, Â, Teleflex, BPH, Bleeding, Infection, University of Wollongong, Patient, Solution, Urinary tract infection, Association, Pelvic pain, TFX, Medical imaging, Pharmaceutical industry

This study explains the mechanism of action through which the UroLift System provides long-term durability and sustained results for patients with benign prostatic hyperplasia (BPH), also referred to as enlarged prostate.

Key Points: 
  • This study explains the mechanism of action through which the UroLift System provides long-term durability and sustained results for patients with benign prostatic hyperplasia (BPH), also referred to as enlarged prostate.
  • The UroLift System implants provide rapid relief from disruptive lower urinary tract symptoms (LUTS) through a minimally invasive procedure that pulls back enlarged prostate tissue.
  • Tissue samples were examined from twenty-four healthy canines and four human patients who were implanted with the UroLift System.
  • Physicians can implant the UroLift System with confidence due to the demonstrated long-term durability and sustained BPH relief that it provides.10
    The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).